The content contained herein is purely for informational purposes and is neither an offer to sell nor a solicitation of an offer to purchase any securities. Such an offer will only be made to pre-qualified investors by means of a confidential private placement memorandum and related subscription documents.

Widening the Scope Through ESG Integration

Hirtle Callaghan is driven by cutting-edge solutions and timeless professional values. We actively seek ways to best represent our client’s values and capture new opportunities that align with our cornerstone investment values of: price discipline, expansive breadth of opportunity, time horizon arbitrage and cost control. One initiative that we are excited about is the integration of environmental, social and governance (ESG) factors into some of our investment programs. Let’s take a closer look at this development and why we think it can be an important piece to the investment puzzle.

read more>>

An Analysis of Tail Risking Strategies

Given today’s elevated global capital markets and decreased VIX levels, many investors are revisiting “tail-risk” strategies for their investment portfolios.  A variety of strategies exist.  Most are designed to mitigate losses from a correction in the equity markets and generally include the use of derivatives to gain synthetic exposure to a particular index.

read more>>

Beneficiary Designations

Do you know who will receive your IRA, Retirement Plan, or Life Insurance proceeds when you die?

Chances are, if you have recently experienced a life event such as: birth of a child or grandchild, marriage, death, or divorce, it is time to review your beneficiary designations.  An annual beneficiary designation review can ensure the desired disposition of your assets.

The last thing you want is to have your $2,000,000 IRA distributed to your ex-spouse at your death.  Unfortunately, this occurs quite frequently due to beneficiary designations not being updated after a divorce.

read more>>

“Why Didn’t We Do That?”

"Why didn’t we have more money in the asset class that outperformed last year?" "Why don’t we add more money to the manager that just beat their benchmark?" "Why don’t we have a higher allocation to hedge funds in the portfolio?" These are questions that I have encountered from new committee members over the last 15 years of participating in hundreds of investment committee meetings.

The rotation of investment committee members on university, foundation, health-care and pension fund investment committees is a fact of life. Recently added members bring a fresh perspective and energy to the committee, yet in many cases they are new to the agreed upon investment structure and philosophy of the organization. Often newer committee members are quiet for the first few meetings as they try to understand the issues and committee dynamics. However, occasionally, newer committee members can be disruptive in committee meetings because they do not have the benefit of knowing why previous decisions were made.

read more>>
First name:
Last name:
Email: